图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:REGULATORY TOXICOLOGY AND PHARMACOLOGY

ISSN:0273-2300
版本:SCI-CDE
出版频率:Monthly
出版社:ACADEMIC PRESS INC ELSEVIER SCIENCE, 525 B ST, STE 1900, SAN DIEGO, USA, CA, 92101-4495
  出版社网址:http://www.apnet.com/
期刊网址:http://www.elsevier.com/inca/publications/store/6/2/2/9/3/9/index.htt
影响因子:3.271
主题范畴:MEDICINE, LEGAL;    PHARMACOLOGY & PHARMACY;    TOXICOLOGY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

Regulatory Toxicology and Pharmacology

Cover Page
  Free Sample Copy
 
 
 

Regulatory Toxicology and Pharmacology, Official Journal of the International Society for Regulatory Toxicology and Pharmacology, reports the concepts and problems involved with the generation, evaluation, and interpretation of experimental animal and human data in the larger perspective of the societal considerations of protecting human health and the environment. The journal is devoted to reports of significant developments, public opinion, scientific data, and ideas that bridge the gap between scientific information and the legal aspects of toxicological and pharmacological regulations.

The journal presents articles concerned with regulatory decisions and with the interpretation of scientific knowledge as influencing regulatory decisions. It is addressed to an International readership of scientists, program managers, research directors, attorneys, and business professionals.


Instructions to Authors

 

Regulatory Toxicology and Pharmacology is the official journal of the International Society of Regulatory Toxicology and Pharmacology. The journal reports significant developments that influence the scientific, statutory, legal, policy, administrative, and enforcement aspects of health, safety, and environmental regulations. Within such a scope, the journal will consider and publish commentaries about policy, legal and social issues, as well as economic studies, and scientific findings in toxicology, pharmacology, epidemiology, ecology, and other disciplines of regulatory significance. The scope of the journal is international.

Submission of Manuscripts. Manuscripts must be written in clear, grammatical English and should be submitted in quadruplicate (one original and three exact photocopies), including four sets of good-quality figures, to


Ms. Sallie W. Carr
Regulatory Toxicology and Pharmacology
6546 Belleview Drive
Columbia, MD 21046-1054, USA
Telephone: (410) 992-9083
Fax: (410) 740-9181
E-mail: rtp-isrtp@erols.com

There are no submission fees or page charges. Review and eventual acceptance could be accelerated if, in addition to the hard copy, submissions are supplied electronically either via e-mail or on 3.5-inch diskettes, reproducing the exact hard-copy submission in plain MS-WORD or rich-text format. Each manuscript should be accompanied by a letter outlining the basic findings of the paper and their significance.

Original papers only will be considered. Manuscripts are accepted for review with the understanding that the same work has not been published, that it is not under consideration for publication elsewhere, and that its submission for publication has been approved by all of the authors and by the institution where the work was carried out; further, that any person cited as a source of personal communications has approved such citation. Written authorization by personal sources may be required at the Editor's discretion. Articles and any other material published in Regulatory Toxicology and Pharmacology represent the opinions of the authors, unless directly endorsed or authorized, should not be construed to reflect the opinions of the International Society of Regulatory Toxicology and Pharmacology, the Editors, or the Publisher.

Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. The Copyright Transfer Agreement should be signed by the appropriate person(s).

Conflict of Intrest Statement. Authors are requested to disclose any possible conflicts of interest. Affiliation of authors submitting manuscripts in their role as members of industrial or government organizations may constitute sufficient discolosure. Academic, nonprofit, consulting, advocacy, and all other authors are asked to disclose in a footnote all sources of financial and material support for the studies and manuscripts submitted.

Peer Review. Submitted manuscripts not rejected at first screen will undergo a peer review process that occasionally could require substantial revision and may last several months, depending on the timeliness of author response.

Electronic Transmission of Accepted Manuscripts. Authors are requested to transmit the text and art of accepted manuscripts in electronic form via standard 3.5-inch disketter or e-mail, after all revisions have been incorporated and the manuscript has been accepted for publication. Submission of accepted manuscripts as an e-mail attachment should be addressed to rtp-isrtp@erols.com, provided that all files are included in a single archive the size of which does not exceed 2 megabytes. Also required are two hard-copy printouts of the manuscript and artwork. The electronic transmission should be in MS-WORD or rich-text format, with figures preferably in PDF format. The manuscript will be edited according to the style of the journal. With the final submission of accepted manuscripts, authors should specify whether they will accept galley proofs electronically in PDF format or as hard copy by mail.

Letters. A brief one-printed-page observation may be published under a "Letters" heading with the understanding that only one reply will be published in a rebuttal. A manuscript intended for publication in Letters or a rebuttal should be so designated when submitted for publication.

Preparation of Manuscript. Authors of scientific reports should make a point to validate whether the data measure what they claim to have measured or whether they could be distorted by adventitious interferences. Authors should also provide evidence that test and control conditions differ only on account of the experimental variables tested, or are not affected by spurious confounding conditions. Conclusions should focus on the most probable explanation of results, but should also endeavor to point out other less apparent but plausible conclusions. Submissions that are not scientific experimental reports, such as policy positions and reviews, should strive for range, logical sequence, clarity, and well-articulated conclusions.

The popularity of Regulatory Toxicology and Pharmacology makes it necessary to severely limit authors' discussions and data presentations in their manuscripts. Because the scope of environmental toxicology and pharmacology is so great, it is not possible to devote many pages to a single issue. Use generic names of chemicals whenever possible. Proprietary names and trademarks should appear only to identify the source of the chemical, and subsequently only the generic name should be used. All abbreviations, other than those for standard units, should be defined in text or in a footnote. Abbreviations should be unpunctuated.

Manuscripts should be double-spaced throughout on one side of 8.5 x 11-inch or A4 white paper. Pages should be numbered consecutively and organized as follows:

The Title Page (p. 1) should contain the article title, authors' names and complete affiliations, footnotes to the title, and the address for manuscript correspondence (including e-mail address and telephone and fax numbers). Separate word counts should be provided for abstract, text, and references. A second page containing only the title of the paper should be submitted if the authors wish to obtain a blind peer review.

The Abstract (p. 2) must be a single paragraph that summarizes the main findings of the paper in less than 200 words. After the abstract a list of up to 10 keywords that will be useful for indexing or searching should be included.

Format. Flexibility of format is allowed, given the mix of multidisciplinary scientific reports and of policy and review articles of interest to the journal. Clarity and brevity will be preferred.

References should be cited in the text by the first author's surname followed by et al. If only two authors are listed, both names should be cited. References should be listed alphabetically by name. Journal names should follow the style of the latest edition of the Chemical Abstracts Service Source Index. Only articles that have been published or are in press should be included in the references. Unpublished results or personal communications should be cited as such in the text.

Gerrity, T.R., Henry, C.J., 1990. Principles of Route-to-Route Extrapolation for Risk Assessment. Elsevier Science, New York.

LaPuma, P.T., Brain S. Rhodes, B.S., 2002. Chromate contenct versus particle size for aircraft paints. Regul. Toxicol. Pharmacol. 36, 318-324.

Mettam, O.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.B., Smith, R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.

Figures should be in a finished form suitable for publication. Number figures consecutively with Arabic numerals, and indicate the top and the authors on the back of each figure. Lettering on drawings should be professional quality or generated by high-resolution computer graphics and must be large enough to withstand appropriate reduction for publication.

Color Figures. Illustrations in color can be accepted only if the authors defray the cost. Mounted color figures must be submitted on paper or flexible board due to the nature of the reproduction process.

Tables should be numbered consecutively with Arabic numerals in order of appearance in the text. Type each table double-spaced on a separate page with a short descriptive title typed directly above and with essential footnotes below. Authors should submit complex tables as camera-ready copy.

Proofs will be sent to the corresponding author in PDF format or hard copy, according to the choice indicated on the final revised submission. To avoid delay in publication, only necessary changes should be made, and proofs should be returned within 48 hours. Authors must read and annotate proofs very carefully, and will be charged for alterations that exceed 10% of the total cost of composition.


Editorial Board

 

Editors:

F. Coulston,, Coulston Foundation, New Mexico, USA
C.J. Carr,, Maryland, USA
Associate Editors:
D. Clayson, Ottawa, Canada
J.P. Frawley, Delaware, USA
G.B. Gori, Maryland, USA
A.W. Hayes, Massachusetts, USA
F. Korte, Attenkirchen, Germany
T. Satoh, Chibah, Japan
Associate Managing Editor:
S.W. Carr,
Editorial Board:
R.H. Adamson, Washington DC, USA
L.E. Arthaud, Texas, USA
D.G. Barnes, Washington DC, USA
L.M. Barraj, Washington DC, USA
J.R. Bender, Ontario, Canada
B.K. Bernard, Washington DC, USA
K.H. Buchel, Leverkusen, Germany
C. Chunming, Beijing, People's Republic of China
J.J. Clary, Michigan, USA
J.A. Del Pup, New York, USA
B.E. Domeyer, Ohio, USA
M. Dourson, Ohio, USA
J. Dwyer, Massachusetts, USA
W.G. Flamm, Washington DC, USA
R.W. Fogleman, Pennsylvania, USA
D.W. Gaylor, Arkansas, USA
M.E. Ginevan, Washington DC, USA
L.S. Gold, California, USA
M. Gough, Maryland, USA
A.M. Guarino, Alabama, USA
J.H. Heckman, Washington DC, USA
D. Henschler, Würzburg, Germany
P.B. Hutt, Washintgon DC, USA
F.R. Johannsen, Missouri, USA
J.G. Keller, Maryland, USA
G. Kimmerle, Gröebenzell, Germany
D. Krewski, Ontario, Canada
Y. Kuroiwa, Tokyo, Japan
L. Lasagna, Massachusetts, USA
J. Lederberg, New York, USA
S.C. Lewis, New Jersey, USA
R.A. McClellan, New Mexico, USA
J.H. Mennear, North Carolina, USA
H. Miyazaki, Kanagawa, Japan
R.J. Moolenaar, Michigan, USA
R. Nilsson, Solna, Sweden
Y. Ohno, Tokyo, Japan
D.J. Paustenbach, California, USA
P. Price, Maine, USA
I.Y. Rosenblum, New Jersey, USA
L. Rosival, Sratislava, Slovakia
R.N. Roth, California, USA
B. Ryffel, Allschwil, Switzerland
R.A. Scala, New Jersey, USA
R.J. Scheuplein, Virginia, USA
R.E. Shore, New York, USA
M.J. Sloan, Washington DC, USA
E. Somers, Ontario, Canada
R.A. Squire, Maryland, USA
B.F. Vincent, Wisconsin, USA
A.P. Wehner, Washington, USA
G.L. Yingling, Washintgon DC, USA


 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有